Company profile
Crystalys Therapeutics
Transforming care for people living with gout.
- Industry
- Biotechnology Research
- Employees
- 20
- Headquarters
- San Diego, California
- Founded
- 2025
- LinkedIn followers
- 2,704
- Office locations
- 1
Crystalys Therapeutics company summary
Crystalys Therapeutics is a company in the Biotechnology Research industry, headquartered in San Diego, California, founded in 2025. On LinkedIn the company has around 20 employees and 2,704 followers.
What technology does Crystalys Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Crystalys Therapeutics
Crystalys is a clinical-stage biopharmaceutical company transforming the treatment of gout. Co-founded by Novo Holdings and Catalys Pacific, Crystalys brings together a world-class team with deep expertise in gout drug development, dedicated to delivering more effective options for people living with gout. Dotinurad, the company’s lead candidate and next-generation URAT1 inhibitor with best-in-class potential for safety and efficacy, is being advanced into global Phase 3 trials as a second-line therapy for gout, supported by extensive clinical data from approvals in multiple Asian markets.
Where is Crystalys Therapeutics located?
Crystalys Therapeutics lists 1 location.
Compare companies similar to Crystalys Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Crystalys Therapeutics crystalystx.com | Biotechnology Research | 20 | 2025 | San Diego, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Crystalys Therapeutics
What does Crystalys Therapeutics do?
Crystalys is a clinical-stage biopharmaceutical company transforming the treatment of gout. Co-founded by Novo Holdings and Catalys Pacific, Crystalys brings together a world-class team with deep expertise in gout drug development, dedicated to delivering more effective options for people living with gout. Dotinurad, the company’s lead candidate and next-generation URAT1 inhibitor with best-in-class potential for safety and efficacy, is being advanced into global Phase 3 trials as a second-line therapy for gout, supported by extensive clinical data from approvals in multiple Asian markets.
How many employees does Crystalys Therapeutics have?
Crystalys Therapeutics has around 20 employees on LinkedIn.
Where is Crystalys Therapeutics headquartered?
Crystalys Therapeutics is headquartered in San Diego, California.
When was Crystalys Therapeutics founded?
Crystalys Therapeutics was founded in 2025.
Build a lead list from companies like Crystalys Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.